Loading...

Maya Katz, MD

Title(s)Associate Professor, Neurology
SchoolSchool of Medicine
Address4150 Clement St.#219G
San Francisco CA 94121
Phone415-353-2273
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    Cornell UniversityB.A.1999College of Arts and Sciences
    Cornell UniversityM.D.2007Weill Medical College
    Mount Sinai Medical CenterResidency2010Neurology
    Mount Sinai Medical CenterChief Resident2011Neurology
    University of California,San FranciscoFellowship2013Movement Disorders
    Collapse Awards and Honors
    2016Parkinson’s Disease Foundation Advancing Parkinson’s Therapies Conference Award
    2015Movement Disorders Society Fostering New Directions in Parkinson’s Research Award

    Collapse Overview 
    Collapse Overview
    Dr. Maya Katz is an Assistant Professor of Neurology at the UCSF Movement Disorders and Neuromodulation Center. She specializes in the treatment of Parkinson's disease, essential tremor, dystonia and other movement disorders. Her research interests include identifying disease modification strategies and improving outcomes for patients treated with deep brain stimulation. She is also interested in developing multidisciplinary clinical approaches that incorporate palliative care principles.

    Dr. Katz obtained her medical degree at Cornell University. She completed her residency in Neurology at Mount Sinai Medical Center, where she served as chief resident. She then completed her Movement Disorders Fellowship at UCSF in 2013. Dr. Katz is board certified in Neurology and is an active member of the American Academy of Neurology and the International Parkinson and Movement Disorder Society.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The presence of a caregiver is associated with patient outcomes in patients with Parkinson's disease and atypical parkinsonisms. Parkinsonism Relat Disord. 2020 Sep; 78:61-65. Prizer LP, Kluger BM, Sillau S, Katz M, Galifianakis NB, Miyasaki JM. PMID: 32736164.
      View in: PubMed   Mentions:    Fields:    
    2. Predictors of general and health-related quality of life in Parkinson's disease and related disorders including caregiver perspectives. Parkinsonism Relat Disord. 2020 08; 77:5-10. Trang I, Katz M, Galifianakis N, Fairclough D, Sillau SH, Miyasaki J, Kluger BM. PMID: 32563809.
      View in: PubMed   Mentions:    Fields:    
    3. Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial. JAMA Neurol. 2020 May 01; 77(5):551-560. Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, Khan R, Friedman C, Cernik W, Goto Y, Long J, Fairclough D, Sillau S, Kutner JS. PMID: 32040141.
      View in: PubMed   Mentions: 1     Fields:    
    4. Associations between spiritual well-being and quality of life in Parkinson disease. Ann Palliat Med. 2020 05; 9(3):1288-1289. Miyasaki JM, Kluger BM, Sillau S, Katz M, Galifianakis N, Prizer LP. PMID: 32312061.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Cervical dystonia incidence and diagnostic delay in a multiethnic population. Mov Disord. 2020 03; 35(3):450-456. LaHue SC, Albers K, Goldman S, Lo RY, Gu Z, Leimpeter A, Fross R, Comyns K, Marras C, de Kleijn A, Smit R, Katz M, Ozelius LJ, Bressman S, Saunders-Pullman R, Comella C, Klingman J, Nelson LM, Van Den Eeden SK, Tanner CM. PMID: 31774238.
      View in: PubMed   Mentions: 1     Fields:    
    6. Telehealth increases access to palliative care for people with Parkinson's disease and related disorders. Ann Palliat Med. 2020 Feb; 9(Suppl 1):S75-S79. Katz M. PMID: 31865746.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Correlates of spiritual wellbeing in persons living with Parkinson disease. Ann Palliat Med. 2020 Feb; 9(Suppl 1):S16-S23. Prizer LP, Kluger BM, Sillau S, Katz M, Galifianakis N, Miyasaki JM. PMID: 31735039.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Framing advance care planning in Parkinson disease: Patient and care partner perspectives. Neurology. 2019 05 28; 92(22):e2571-e2579. Lum HD, Jordan SR, Brungardt A, Ayele R, Katz M, Miyasaki JM, Hall A, Jones J, Kluger B. PMID: 31028124.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    9. Does outpatient palliative care improve patient-centered outcomes in Parkinson's disease: Rationale, design, and implementation of a pragmatic comparative effectiveness trial. Contemp Clin Trials. 2019 04; 79:28-36. Kluger BM, Katz M, Galifianakis N, Pantilat SZ, Kutner JS, Sillau S, Gritz M, Jones J, Fairclough D, Sumrall M, Hall K, Miyasaki J. PMID: 30779960.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    10. Top Ten Tips Palliative Care Clinicians Should Know About Parkinson's Disease and Related Disorders. J Palliat Med. 2018 10; 21(10):1507-1517. Katz M, Goto Y, Kluger BM, Galifianakis NB, Miyasaki JM, Kutner JS, Jones CA, Pantilat SZ. PMID: 30204543.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Neuropalliative care: Priorities to move the field forward. Neurology. 2018 07 31; 91(5):217-226. Creutzfeldt CJ, Kluger B, Kelly AG, Lemmon M, Hwang DY, Galifianakis NB, Carver A, Katz M, Curtis JR, Holloway RG. PMID: 29950434.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    12. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017 Sep 12; 89(11):1152-1161. Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Aldred J, Carter J, Fraser A, Jimenez-Shahed J, Hunter C, Spindler M, Reichwein S, Mari Z, Dunlop B, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Mejia NI, Bwala G, Nance M, Shih LC, Singer C, Vargas-Parra S, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Dhall R, Hassan A, DeMello S, Riggare SS, Wicks P, Achey MA, Elson MJ, Goldenthal S, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W. PMID: 28814455.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    13. Virtual visits for Parkinson disease: A multicenter noncontrolled cohort. Neurol Clin Pract. 2017 08; 7(4):283-295. Korn RE, Wagle Shukla A, Katz M, Keenan HT, Goldenthal S, Auinger P, Zhu W, Dodge M, Rizer K, Achey MA, Byrd E, Barbano R, Richard I, Andrzejewski KL, Schwarz HB, Dorsey ER, Biglan KM, Kang G, Kanchana S, Rodriguez R, Tanner CM, Galifianakis NB. PMID: 28840919.
      View in: PubMed   Mentions:
    14. Parkinson's disease patient preference and experience with various methods of DBS lead placement. Parkinsonism Relat Disord. 2017 Aug; 41:25-30. LaHue SC, Ostrem JL, Galifianakis NB, San Luciano M, Ziman N, Wang S, Racine CA, Starr PA, Larson PS, Katz M. PMID: 28615151.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. Palliative care and Parkinson's disease: Meeting summary and recommendations for clinical research. Parkinsonism Relat Disord. 2017 04; 37:19-26. Kluger BM, Fox S, Timmons S, Katz M, Galifianakis NB, Subramanian I, Carter JH, Johnson MJ, Richfield EW, Bekelman D, Kutner JS, Miyasaki J. PMID: 28108265.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    16. Bilateral Ventral Intermediate Nucleus Thalamic Deep Brain Stimulation in Orthostatic Tremor. Stereotact Funct Neurosurg. 2016; 94(2):69-74. Coleman RR, Starr PA, Katz M, Glass GA, Volz M, Khandhar SM, Ostrem JL. PMID: 27002536.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    17. National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers. Telemed J E Health. 2016 07; 22(7):590-8. Dorsey ER, Achey MA, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Ziman N, Aldred J, Carter J, Jimenez-Shahed J, Hunter C, Spindler M, Mari Z, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Bull MT, Mejia NI, Bwala G, Nance M, Shih L, Anderson L, Singer C, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Cooper J, Webb S, Dhall R, Hassan A, Weis D, DeMello S, Riggare SS, Wicks P, Smith J, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W. PMID: 26886406.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    18. Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid. Neurotherapeutics. 2016 Jan; 13(1):217-25. Reyes RC, Cittolin-Santos GF, Kim JE, Won SJ, Brennan-Minnella AM, Katz M, Glass GA, Swanson RA. PMID: 26572666.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    19. Erratum to: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid. Neurotherapeutics. 2016 Jan; 13(1):239. Reyes RC, Cittolin-Santos GF, Kim JE, Won SJ, Brennan-Minnella AM, Katz M, Glass GA, Swanson RA. PMID: 26659493.
      View in: PubMed   Mentions:    Fields:    
    20. Effective Interventional Magnetic Resonance Image-Guided Laser Ablations in a Parkinson's Disease Patient with Refractory Tremor. Mov Disord Clin Pract. 2016 May-Jun; 3(3):312-314. San Luciano M, Katz M, Ostrem J, Martin A, Starr P, Ziman N, Larson P. PMID: 30713924.
      View in: PubMed   Mentions:
    21. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. J Neurosurg. 2016 Apr; 124(4):908-16. Ostrem JL, Ziman N, Galifianakis NB, Starr PA, Luciano MS, Katz M, Racine CA, Martin AJ, Markun LC, Larson PS. PMID: 26495947.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    22. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease. Ann Neurol. 2015 Apr; 77(4):710-9. Katz M, Luciano MS, Carlson K, Luo P, Marks WJ, Larson PS, Starr PA, Follett KA, Weaver FM, Stern MB, Reda DJ, Ostrem JL. PMID: 25627340.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    23. Cerebrospinal fluid concentrations of N-acetylcysteine after oral administration in Parkinson's disease. Parkinsonism Relat Disord. 2015 May; 21(5):500-3. Katz M, Won SJ, Park Y, Orr A, Jones DP, Swanson RA, Glass GA. PMID: 25765302.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    24. Supplemental oxygen delivery to suspected stroke patients in pre hospital and emergency department settings. Med Gas Res. 2014; 4:16. Chan YF, Katz M, Moskowitz A, Levine SR, Richardson LD, Tuhrim S, Chason K, Barsan-Silverman K, Singhal A. PMID: 26413266.
      View in: PubMed   Mentions: 1     Fields:    
    25. Focal task-specific lower extremity dystonia associated with intense repetitive exercise: a case series. Parkinsonism Relat Disord. 2013 Nov; 19(11):1033-8. Katz M, Byl NN, San Luciano M, Ostrem JL. PMID: 23932354.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. Longitudinal impedance variability in patients with chronically implanted DBS devices. Brain Stimul. 2013 Sep; 6(5):746-51. Cheung T, Nuño M, Hoffman M, Katz M, Kilbane C, Alterman R, Tagliati M. PMID: 23619246.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    27. Rocuronium as muscle relaxant for electroconvulsive therapy in a patient with adult-onset muscular dystrophy. J ECT. 2011 Dec; 27(4):e63-4. Bryson EO, Aloysi AS, Katz M, Popeo D, Kellner CH. PMID: 22124227.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Referring patients for deep brain stimulation: an improving practice. Arch Neurol. 2011 Aug; 68(8):1027-32. Katz M, Kilbane C, Rosengard J, Alterman RL, Tagliati M. PMID: 21825238.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    29. Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis. 2011; 27(1):211-23. Dumont M, Kipiani K, Yu F, Wille E, Katz M, Calingasan NY, Gouras GK, Lin MT, Beal MF. PMID: 21799249.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    Maya's Networks
    Concepts (124)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (14)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑